Cell Source Inc
OTC:CLCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cell Source Inc
OTC:CLCS
|
US |
|
M
|
Madison Pacific Properties Inc
TSX:MPC.C
|
CA |
|
E
|
East Africa Metals Inc
F:EA1
|
CA |
|
Goldhaven Resources Corp
OTC:GHVNF
|
CA |
|
C
|
Check Cap Ltd
SWB:7CC
|
IL |
|
Hexagon Energy Materials Ltd
ASX:NH3
|
AU |
|
China Xuefeng Environmental Engineering Inc
OTC:ELEK
|
CN |
|
CanXGold Mining Corp.
F:L93
|
CA |
|
E
|
Europacific Metals Inc
F:9FY0
|
CA |
|
D
|
Diploma PLC
F:DP9
|
UK |
|
3
|
3Dshopping.Com
OTC:THDS
|
US |
|
T
|
Tureks Turunc Madencilik Ic ve Dis Ticaret AS
IST:MARBL.E
|
TR |
|
C
|
Centaurus Energy Inc
OTC:CTARF
|
CA |
|
Capstone Energy+ Inc
NASDAQ:CEPL
|
US |
|
AlJazira REIT
SAU:4331
|
SA |
|
S
|
Sana Industries Ltd
KAR:SNAI
|
PK |
|
R
|
Rockhaven Resources Ltd
XMUN:8RR
|
CA |
|
E
|
Endurance Gold Corp
F:3EG
|
CA |
|
X
|
XP Chemistries AB
F:86Q
|
SE |
Bankruptcy Probability
Cell Source Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cell Source Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cell Source Inc
OTC:CLCS
|
44m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
442.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
76.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cell Source Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cell Source Inc has total debt of 1.2m USD. This includes both short-term (1.2m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
